Free Trial

Kingsman Wealth Management Inc. Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intuitive Surgical logo with Medical background

Kingsman Wealth Management Inc. bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,221 shares of the medical equipment provider's stock, valued at approximately $1,100,000. Intuitive Surgical comprises about 0.8% of Kingsman Wealth Management Inc.'s investment portfolio, making the stock its 24th biggest holding.

Several other large investors have also recently made changes to their positions in ISRG. Chilton Capital Management LLC grew its position in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 43 shares during the period. Parvin Asset Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $26,000. Global Financial Private Client LLC lifted its holdings in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares during the last quarter. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter valued at $26,000. Finally, Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director owned 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president directly owned 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock valued at $2,611,577 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. Truist Financial dropped their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their target price for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Citigroup reaffirmed a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Barclays cut their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $592.86.

Check Out Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Stock Down 0.5%

ISRG traded down $2.50 during trading on Monday, hitting $516.12. The company's stock had a trading volume of 1,638,346 shares, compared to its average volume of 1,666,208. The stock has a market capitalization of $184.99 billion, a price-to-earnings ratio of 81.42, a price-to-earnings-growth ratio of 5.50 and a beta of 1.64. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm's 50 day moving average price is $535.90 and its two-hundred day moving average price is $536.29.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter in the prior year, the business earned $1.50 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines